Gewinn- und Verlustrechnung von Pacific Biosciences of

globenewswire.com2026-10-06 09:05:00

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio's drug discovery models PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio's drug discovery models

zacks.com2026-10-02 19:15:59

Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts

Pacific Biosciences of California (PACB) concluded the recent trading session at $2.54, signifying a +1.2% move from its prior day's close.

schaeffersresearch.com2026-10-01 11:44:35

3 Biotech Stocks Put Traders Are Targeting Today

Nektar Therapeutics (NASDAQ:NKTR), Quantum-Si Inc (NASDAQ:QSI), and Pacific Biosciences of California Inc (NASDAQ:PACB) are all attracting elevated options activity today, as biotech stocks make volatile moves.

defenseworld.net2026-10-01 03:42:46

Pacific Biosciences of California (NASDAQ:PACB) Stock Sees Heavy Call Option Buying

Pacific Biosciences of California, Inc. (NASDAQ: PACB - Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 13,687 call options on the stock. This represents an increase of 795% compared to the average volume of 1,530 call options. Wall Street Analysts Forecast Growth Several analysts have recently weighed in

defenseworld.net2026-09-30 06:21:12

Pacific Biosciences of California (NASDAQ:PACB) Shares Climb 6.1% – Still a Buy?

Shares of Pacific Biosciences of California, Inc. (NASDAQ: PACB - Get Free Report) rose 6.1% on Monday. The company traded as high as $1.68 and last traded at $1.7190. 2,798,059 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 6,597,147 shares. The stock had previously closed at $1.62. Wall

zacks.com2026-09-25 19:15:19

Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.62, marking a +2.53% move from the previous day.

marketbeat.com2026-09-20 02:03:35

Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push

Pacific Biosciences of California NASDAQ: PACB is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve sequencing economics, Chief Executive Officer Mark Van Oene said during a Morgan Stanley discussion.

zacks.com2026-09-17 19:15:53

Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today

In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.38, indicating a +2.99% shift from the previous trading day.

seekingalpha.com2026-09-16 05:02:08

Pacific Biosciences of California, Inc. (PACB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

zacks.com2026-09-10 19:15:53

Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know

Pacific Biosciences of California (PACB) closed at $1.27 in the latest trading session, marking a -1.55% move from the prior day.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft

Gewinn- und Verlustrechnung von Pacific Biosciences of California, Inc.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft